扫描下面的二维码:
"中文幻灯"标签列表
POTENTIAL NEGATIVE IMPACT OF AGING ON HEPATOCARCINOGENESIS AFTER ANTI-VIRAL TREATMENT2008-04-30
PATHOPHYSIOLOGY OF PORTAL HYPERTENSION2008-04-30
NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IS ASSOCIATED WITH HIGHER OVERALL MORTALITY AND LIVER RELA2008-04-30
HEPATOCELLULAR CARCINOMA 20082008-04-30
INTERFERON REGULATED GENE EXPRESSION IN THE LIVER DETERMINES RESPONSE TO TREATMENT IN CHRONIC HEPATI2008-04-30
HEMODYNAMIC EFFECTS AND SAFETY OF ONE-MONTH SIMVASTATIN TREATMENT2008-04-30
Hepatitis B THE Problem of drug resistance2008-04-30
HBX BINDS IN VIVO ON THE HBV MINICHROMOSOME, MODIFIES THE EPIGENETIC REGULATION OF CCC-DNA FUNCTION 2008-04-30
HBV LIFE CYCLE CAN WE FIND NOVEL ANTIVIRAL TARGETS2008-04-30
FACTORS PREDICTIVE OF RELAPSE IN GENOTYPE 2 AND 3 PTS TREATED FOR 12 WEEKS WITH PEGIFN ALFA 2B AND W2008-04-30
EXHAUSTION AND FUNCTIONAL RESTORATION OF INTRAHEPATIC HBV SPECIFIC T CELLS IN CHRONIC HEPATITIS B2008-04-30
EFFICAY AND SAFETY OF PEGYLATED INTERFERON AND RIBAVIRIN IN HCV-INFECTED PATIENTS AWAITING LIVER TRA2008-04-30
CYTOPROTECTIVE EFFECTS OF EXENDIN-4, A GLP-1 RECEPTOR AGONIST, ON THE BILIARY THELIUM2008-04-30
Molecular genetics of intrahepatic cholestasis2008-04-30
Autoimmune hepatitis2008-04-30
Coagulopathy and coagulation tests in cirrhosis2008-04-30
Portal pressure and new strategies for prophylaxis of variceal bleeding2008-04-30
Tailored therapy for chronic hepatitis B2008-04-30
Chronic Hepatitis B, who should be treated?: debate between experts2008-04-30
Antiviral therapy for HBV: is it really cost-effective?2008-04-30